KBL MERGER CORP. IV Business Finance Contracts & Agreements

79 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Securities Purchase Agreement
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2024
Form of Common Stock Purchase Warrant (December 2024 Offering)
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2024
Form of Warrant Inducement Agreement, by and between the Company and Holder
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2024
Form of Warrant to Purchase Shares of Common Stock
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2024
Common Stock Purchase Warrant to purchase 3,000,000 shares of common stock dated September 30, 2024, granted by 180 Life Sciences Corp. to Elray Resources, Inc
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2024
Asset Purchase Agreement dated September 29, 2024, by and among Elray Resources, Inc., as seller and 180 Life Sciences Corp., as purchaser
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2024
Amendment No.1 to the Securities Purchase Agreement, dated November 28, 2023, by and between 180 Life Sciences Corp. and the Purchaser
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
2023
Warrant Amendment Agreement, dated November 28, 2023, by and between the Company and the Purchaser
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2023
Form of Warrant Agent Agreement for Pre-Funded Warrants and Common Warrants
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Securities Purchase Agreement dated August 9, 2023, by and between 180 Life Sciences Corp. and the Institutional Investor
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Warrant Amendment Agreement, dated August 9, 2023, by and between the Company and Armistice Capital Master Fund Ltd
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2023
Warrant Agent Agreement for Pre-Funded Warrants and Common Warrants, dated August 14, 2023, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Form of Warrant Agent Agreement for Pre-Funded Warrants and Common Warrants
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Form of Securities Purchase Agreement
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Form of Common Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Form of Pre-Funded Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Amendment No. 1 to Common Stock Purchase Warrant between 180 Life Sciences Corp. and the warrant holder, dated April 5, 2023
Stock Agreements
KBL MERGER CORP. IV
Biotechnology
2023
Warrant Agent Agreement for the July 2022 Common Warrants, dated July 29, 2022, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Warrant Agent Agreement for Common Warrants, dated April 10, 2023 by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Warrant Agent Agreement for Pre-Funded Warrants, dated April 10, 2023 by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Securities Purchase Agreement, dated April 5, 2023, by and between 180 Life Sciences Corp. and the Purchaser
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Form of Common Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Form of Pre-Funded Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Amendment to the Warrant Agent Agreement, dated January 13, 2023, by and between 180 Life Sciences Corp. and the Warrant Agent
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2023
Warrant Amendment, dated January 12, 2023, by and between 180 Life Sciences Corp. and the Purchaser
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2023
Warrant Agent Agreement for the Common Warrants, dated December 22, 2022, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2022
Warrant Agent Agreement for the Pre-Funded Warrants, dated December 22, 2022, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2022
Securities Purchase Agreement, dated December 20, 2022, by and between 180 Life Sciences Corp. and the Purchaser
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2022
Form of Common Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2022
Form of Pre-Funded Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2022
Securities Purchase Agreement dated July 17, 2022, by and between 180 Life Sciences Corp. and the Purchaser
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2022
Form of Common Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2022
Form of Pre-Funded Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2022
Registration Rights Agreement dated as of August 23, 2021 by and between 180 Life Sciences Corp. and the purchasers signatory thereto
Registration Rights Agreements
KBL MERGER CORP. IV
Biotechnology
2021
Securities Purchase Agreement dated as of August 19, 2021 by and between 180 Life Sciences Corp. and the purchasers identified on the signature pages thereto
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2021
Form of Purchaser Warrant (August 2021 Offering)
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2021
Form of Stock Option Agreement (Independent Directors August 2021 Grants)
Stock Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2021
Common Stock Purchase Warrant dated July 31, 2021, to purchase 25,000 shares of common stock of 180 Life Sciences Corp., granted to Alpha Capital Anstalt
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2021
Dr. Lawrence Steinman Confirmation of Rescission of Note Amendments effective February 25, 2021
Note Agreements
KBL MERGER CORP. IV
Biotechnology
2021
Sir Marc Feldmann Confirmation of Rescission of Note Amendments effective February 25, 2021
Note Agreements
KBL MERGER CORP. IV
Biotechnology
2021